Back to Search Start Over

Association of GRIA1 polymorphisms with ovarian response to human menopausal gonadotropin in Iranian women.

Authors :
Golestanpour H
Javadi G
Sheikhha MH
Source :
Clinical and experimental reproductive medicine [Clin Exp Reprod Med] 2020 Sep; Vol. 47 (3), pp. 207-212. Date of Electronic Publication: 2020 Aug 24.
Publication Year :
2020

Abstract

Objective: Glutamate ionotropic receptor AMPA type subunit 1 (GRIA1) is a subunit of a ligand-gated ion channel that regulates the secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) by controlling the release of gonadotropin-releasing hormone. Few studies have investigated the association between the GRIA1 gene and human infertility. This study evaluated the association of the GRIA1 rs548294 C > T and rs2195450 G > A polymorphisms with the ovarian response to human menopausal gonadotropin (HMG) in Iranian women.<br />Methods: One hundred women with histories of at least 1 year of infertility were included. On the second day of menstruation, patients were injected with HMG; on the third day, blood samples were collected. After hormonal analysis, the GRIA1 rs548294 C > T and rs2195450 G > A genotypes of samples were identified via the restriction fragment length polymorphism method, and on day 9, the number of follicles was assessed via ultrasound.<br />Results: For the GRIA1 rs548294 C > T and rs2195450 G > A single nucleotide polymorphisms, the subjects with CT and GG genotypes, respectively, displayed the highest mean FSH level, LH level, and number of follicles on day 9 of the menstrual cycle (p< 0.05). Significant positive correlations were observed between LH and FSH (p< 0.01), LH and follicle count (p< 0.01), FSH and age (p< 0.05), follicle count and age (p= 0.048), and FSH and follicle count (p< 0.01).<br />Conclusion: This study showed a significant relationship between GRIA1 polymorphisms and ovarian response to the induction of ovulation. Therefore, determining patients' GRIA1 genotype may be useful for improving treatment and prescribing suitable doses of ovulation-stimulating drugs.

Details

Language :
English
ISSN :
2233-8233
Volume :
47
Issue :
3
Database :
MEDLINE
Journal :
Clinical and experimental reproductive medicine
Publication Type :
Academic Journal
Accession number :
32829568
Full Text :
https://doi.org/10.5653/cerm.2020.03370